反馈
设置

设置

查看申请

428,992 个结果
专利局 all 语言 zh 词根提取 true 单一族成员 false 包括NPL false
只有拥有WIPO帐户才能生成RSS源

保存查询

私人查询仅在您登录后对您可见，而不能在RSS 订阅中使用

查询树

优化选项

专利局
全部
指明检索关键词的语言
词根提取功能可将屈折词还原回词根形式。
例如，fishing、fished、fish 和 fisher 这些词都会还原回词根 fish，
因此检索 fisher 即可获得各种变形的所有结果
仅返回专利族的一个成员
在结果中包括非专利文献

完整查询

CTR:MX

并排视图快捷键

一般快捷键
转到检索输入栏
CTRL + SHIFT +
转到结果（选定结果）
CTRL + SHIFT +
转到详细信息（选定标签）
CTRL + SHIFT +
转到下一页
CTRL +
转到上一页
CTRL +
结果（首先，执行“转到结果”）
转到下一个结果/图像
/
转到上一个结果/图像
/
向上滚动
Page Up
向下滚动
Page Down
滚动至顶部
CTRL + Home
滚动至底部
CTRL + End
详细信息（首先，执行“转到详细信息”）
转到下一个标签
转到上一个标签

分析

1 / 42,900
1.MX/a/2008/014687PREDICTION OF RELATIVE POLYPEPTIDE SOLUBILITY BY POLYETHYLENE GLYCOL PRECIPITATION
MX - 27.01.2009
国际分类 G01N 33/68
G物理
01用于测量的传感器,如敏感元件
N借助于测定材料的化学或物理性质来测试或分析材料
33利用不包括在G01N1/00至G01N31/00组中的特殊方法来研究或分析材料
48生物物质,例如血、尿;血球计数器
50生物物质(例如血、尿)的化学分析;包括了生物特有的配体结合方法的测试;免疫学试验
68涉及蛋白质、肽或氨基酸的
 申请号 MX/a/2008/014687 申请人 WYETH.* 发明人 NICHOLAS W. WARNE
A method is described for predicting the relative solubility of a polypeptide using polyethylene glycol (PEG) based volume exclusion precipitation. Different polypeptides can be tested for their solubilities relative to each other or relative to a reference. A single polypeptide can be tested for its relative solubility under different experimental conditions. The solubility determinations can be made by comparison based on graphs plotting the log solubility of the polypeptide against a range of PEG concentrations. Additionally, a method is provided for the high throughput visual or automated screening of multiple polypeptides for relative solubility differences, in a method that can omit the step of measuring the actual solubility or actual amount of precipitation of each sample at each PEG concentration.
2.MX/a/2008/014793METHODS OF TREATING STROKE
MX - 12.02.2009
国际分类 A01N 37/18
A人类生活必需
01农业;林业;畜牧业;狩猎;诱捕;捕鱼
N杀生剂
37含有机化合物的杀生剂、害虫驱避剂或引诱剂,或植物生长调节剂,该有机化合物含带有3个连于杂原子的键的碳原子,其中至多有两个键连于卤素,例如羧酸
18含有CON基团,例如羧酸酰胺或酰亚胺;其硫代类似物
 申请号 MX/a/2008/014793 申请人 BIOGEN IDEC MA INC. 发明人 JANE K. RELTON
Methods and compositions for treating stroke are disclosed.
3.MX/a/2008/014959COMPOUNDS AND METHODS FOR MODULATING FXR
MX - 12.02.2009
国际分类 A61K 31/4192
A人类生活必需
61医学或兽医学;卫生学
K医用、牙科用或梳妆用的制剂
31含有机有效成分的医药配制品
33杂环化合物
395有氮作为环杂原子的,例如胍乙啶、利福霉素
41有两个或两个以上环杂原子的五元环的,其中至少有1个氮原子,例如四唑
41921,2,3-Triazoles
 申请号 MX/a/2008/014959 申请人 ELI LILLY AND COMPANY. 发明人 Tianwei Ma
Compounds of formula (I) wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and related diseases.
4.MX/a/2008/015045DECODING OF PREDICTIVELY CODED DATA USING BUFFER ADAPTATION
MX - 12.02.2009
国际分类 G10L 19/04
G物理
10乐器;声学
L语音分析技术或语音合成;语音识别;语音或声音处理技术;语音或音频编码或解码
19用于冗余度下降情形(例如在声码器中)的语音或音频信号分析-合成技术;语音或音频信号编码或解码,采用源滤波器模型或心理声学分析
04利用预测技术
 申请号 MX/a/2008/015045 申请人 NOKIA CORPORATION 发明人 JUHA OJANPERA
A decoder (e.g., an AAC-LTP decoder) receives a stream containing coded audio data and prediction data. The coded data is upsampled or downsampled during decoding. Portions of the decoded data are stored in a buffer for use in decoding subsequent coded data. The buffer into which the decoded data is placed has different dimensions than a buffer used in a coder when generating the coded data. A portion of the data in the decoder buffer is identified and modified with interleaved zero values so as to correspond to the dimensions of the prediction coding buffer in the coder.
5.MX/a/2008/015268BASEPAN ASSEMBLY FOR AN ELECTRICAL PANEL
MX - 12.02.2009
国际分类 H02B 1/056
H电学
02发电、变电或配电
B供电或配电用的配电盘、变电站或开关装置
1框架、盘、板、台、机壳;变电站或开关装置的零部件
015盘、板、台;它们的部件或相应的配件
04开关或其他一般装置在其上的安装,该开关或装置有或无外壳
056安装在插接板上的
 申请号 MX/a/2008/015268 申请人 SIEMENS ENERGY&AUTOMATION, INC.* 发明人 Joseph Scott Dixon
A system comprising:a basepan assembly for an electrical panel, said basepan assembly made up of an interconnectable plurality of pieces, a first piece from said plurality of pieces comprising:an inserter;and a reciever adapted to slidably recieve an inserter of a second piece from said plurality of pieces and, for each of three mutually perpendicular axes, to releasably restrain said second piece from moving relative to said first piece in at least one direction parallel to said axis;in an operative embodiment, said basepan assembly adapted to:retain a plurality of bus bars to said electrical panel;mutually align said plurality of bus bars;restrain motion of said plurality of bus bars in said one or more directions parallel to any of said three mutually perpendicular axes;and mutually electrically insulate said pluralityof bus bars.
6.MX/a/2008/015303USE OF STARCH WITH SYNTHETIC METAL SILICATES FOR IMPROVING A PAPERMAKING PROCESS
MX - 12.02.2009
国际分类 D21H 17/28
D纺织;造纸
21造纸;纤维素的生产
H浆料或纸浆组合物;不包括在小类D21C、D21D中的纸浆组合物的制备;纸的浸渍或涂布;不包括在大类B31或小类D21G中的成品纸的加工;其他类不包括的纸
17添加到纸浆的非纤维材料,特征在于其组分;特征在于其组分的纸浸渍材料
20高分子有机化合物
21天然原料的;其衍生物
24多糖
28淀粉
 申请号 MX/a/2008/015303 申请人 NALCO COMPANY 发明人 JANE B. WONG SHING
The invention discloses a paper or paperboard produced from a slurry comprising cellulose fibers and an effective amount of SMS. In addition, a method for increasing retention and dewatering during the papermaking process is also disclosed. The method involves the addition of an effective amount of SMS to said papermaking process. The invention also discloses a method for increasing retention and drainage in a papermaking process comprising the steps of:adding both an effective amount of starch and an effective amount of SMS to a slurry of said papermaking process, wherein said starch is selected from the group consisting of:tapioca starch;potato starch;corn starch;waxy maize starch;rice starch;and wheat starch. Moreover, the invention comprises a method for increasing retention and drainage in a papermaking process comprising the steps of:adding both an effective amount of modified starch and an effective amount of SMS to a slurry of said papermaking process.
7.MX/a/2008/0153084-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM
MX - 12.02.2009
国际分类 A61K 31/4985
A人类生活必需
61医学或兽医学;卫生学
K医用、牙科用或梳妆用的制剂
31含有机有效成分的医药配制品
33杂环化合物
395有氮作为环杂原子的,例如胍乙啶、利福霉素
495有仅以两个氮原子作为环杂原子的六元环,例如哌嗪
4985与杂环邻位或迫位稠合的吡嗪或哌嗪
 申请号 MX/a/2008/015308 申请人 ELBION GMBH 发明人 Norbert HÖFGEN
The invention relates to 4-amino-pyrido[3,2-e]pyrazines, to processes for preparing them, to pharmaceutical preparations which comprise these compounds and to the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 10, as active compounds for treating diseases of mammals including a human which can be influenced by using the compounds according to the invention to inhibit phosphodiesterase 10 activity in the central nervous system. More particularly, the invention relates to the treatment of neurologic and psychiatric disorders, for example psychosis and disorders comprising cognitive deficits as symptoms.
8.MX/a/2008/015328BENZOXAZOLE AND BENZOTHIAZOLE DERIVATIVES AS 5-HYDROXYTRYTAMINE-6 LIGANDS
MX - 12.02.2009
国际分类 A61K 31/423
A人类生活必需
61医学或兽医学;卫生学
K医用、牙科用或梳妆用的制剂
31含有机有效成分的医药配制品
33杂环化合物
395有氮作为环杂原子的,例如胍乙啶、利福霉素
41有两个或两个以上环杂原子的五元环的,其中至少有1个氮原子,例如四唑
42口恶唑
423与碳环稠合的
 申请号 MX/a/2008/015328 申请人 WYETH.* 发明人 HASSAN MAHMOUD ELOKDAH
The present invention provides a compound of Formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
9.MX/a/2008/015350INJECTION DEVICE WITH SYRINGE CARRIER ENGAGEMENT WITH CAP
MX - 12.02.2009
国际分类 A61M 5/20
A人类生活必需
61医学或兽医学;卫生学
M将介质输入人体内或输到人体上的器械;为转移人体介质或为从人体内取出介质的器械;用于产生或结束睡眠或昏迷的器械
5以皮下注射、静脉注射或肌内注射的方式将介质引入体内的器械;其附件,例如充填或清洁器、靠手
178注射器
20自动注射器,例如用自动推动的活塞杆的,用自动针头注射的,自动填充
 申请号 MX/a/2008/015350 申请人 CILAG GMBH INTERNATIONAL 发明人 BRADY, Matthew James
An injection device (110) is described having a housing (112) that receives a syringe (114) having a needle (118), wherein the syringe is supported in a syringe carrier (150). The injection device (110) has a removable cap (190). The syringe (114) and syringe carrier (150) are biased by a return spring (126) from an extended position in which the needle (118) extends from the housing (112) through an exit aperture (128) to a retracted position in which it does not. The syringe carrier (150) abuts a surface inside the removable cap (190) which prevents forward movement of the syringe carrier (150) when the cap is in place. The injection device is less prone to failure than prior art devices and is safer should failure occur.
10.MX/a/2008/015395USE OF CD83 IN COMBINATION THERAPIES
MX - 12.02.2009
国际分类 A61K 48/00
A人类生活必需
61医学或兽医学;卫生学
K医用、牙科用或梳妆用的制剂
48含有插入到活体细胞中的遗传物质以治疗遗传病的医药配制品;基因治疗
 申请号 MX/a/2008/015395 申请人 ARGOS THERAPEUTICS, INC. 发明人 CHARLES NICOLETTE
The present invention relates to improved methods of suppressing and/or preventing an undesired immune response comprising the use of CD83. In some embodiments, CD83 is coadministered to a subject with at least one other immunosuppressive compound. Methods are also provided for generating tolerogenic dendritic cells and regulatory T cells. These cells can be used in vitro to produce additional cells for therapeutic purposes or they can be used in vivo to suppress and/or prevent an undesired immune response. Methods of the invention can be used to prevent or reduce the severity of autoimmune diseases and can also be used to induce tolerance to at least one therapeutic composition, such as a therapeutic protein or transplanted tissue.
# -